Sumitomo Life Insurance’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $307K | Buy |
1,672
+67
| +4% | +$12.3K | 0.01% | 266 |
|
|
2025
Q4 | $282K | Sell |
1,605
-12
| -0.7% | -$1.96K | 0.01% | 270 |
|
|
2025
Q3 | $227K | Sell |
1,617
-39
| -2% | -$5.27K | 0.01% | 265 |
|
|
2025
Q2 | $208K | Sell |
1,656
-55
| -3% | -$6.85K | 0.01% | 263 |
|
|
2025
Q1 | $234K | Sell |
1,711
-19
| -1% | -$2.72K | 0.01% | 268 |
|
|
2024
Q4 | $265K | Sell |
1,730
-2,176
| -56% | -$367K | 0.01% | 265 |
|
|
2024
Q3 | $757K | Buy |
3,906
+162
| +4% | +$33.9K | 0.01% | 224 |
|
|
2024
Q2 | $868K | Sell |
3,744
-461
| -11% | -$100K | 0.02% | 198 |
|
|
2024
Q1 | $907K | Sell |
4,205
-186
| -4% | -$43.6K | 0.02% | 204 |
|
|
2023
Q4 | $1.14M | Sell |
4,391
-228
| -5% | -$56K | 0.04% | 165 |
|
|
2023
Q3 | $1.19M | Sell |
4,619
-61
| -1% | -$16.3K | 0.03% | 151 |
|
|
2023
Q2 | $1.33M | Sell |
4,680
-438
| -9% | -$130K | 0.06% | 147 |
|
|
2023
Q1 | $1.42M | Sell |
5,118
-52
| -1% | -$14.4K | 0.12% | 136 |
|
|
2022
Q4 | $1.43M | Sell |
5,170
-278
| -5% | -$78.5K | 0.11% | 131 |
|
|
2022
Q3 | $1.46M | Sell |
5,448
-398
| -7% | -$84.5K | 0.06% | 125 |
|
|
2022
Q2 | $1.19M | Buy |
5,846
+192
| +3% | +$39.3K | 0.03% | 167 |
|
|
2022
Q1 | $1.19M | Sell |
5,654
-192
| -3% | -$41.8K | 0.03% | 187 |
|
|
2021
Q4 | $1.4M | Sell |
5,846
-157
| -3% | -$40.4K | 0.03% | 173 |
|
|
2021
Q3 | $1.7M | Sell |
6,003
-254
| -4% | -$83.2K | 0.05% | 141 |
|
|
2021
Q2 | $2.17M | Sell |
6,257
-974
| -13% | -$295K | 0.07% | 107 |
|
|
2021
Q1 | $2.02M | Sell |
7,231
-299
| -4% | -$80.6K | 0.08% | 126 |
|
|
2020
Q4 | $1.84M | Sell |
7,530
-884
| -11% | -$228K | 0.08% | 135 |
|
|
2020
Q3 | $2.39M | Sell |
8,414
-439
| -5% | -$122K | 0.11% | 98 |
|
|
2020
Q2 | $2.37M | Sell |
8,853
-747
| -8% | -$225K | 0.13% | 93 |
|
|
2020
Q1 | $3.04M | Buy |
9,600
+130
| +1% | +$39.5K | 0.22% | 64 |
|
|
2019
Q4 | $2.81M | Buy |
9,470
+533
| +6% | +$148K | 0.32% | 89 |
|
|
2019
Q3 | $2.08M | Sell |
8,937
-1,142
| -11% | -$266K | 0.27% | 109 |
|
|
2019
Q2 | $2.36M | Buy |
10,079
+407
| +4% | +$94K | 0.28% | 99 |
|
|
2019
Q1 | $2.29M | Sell |
9,672
-1,121
| -10% | -$353K | 0.31% | 102 |
|
|
2018
Q4 | $3.25M | Buy |
10,793
+283
| +3% | +$90.3K | 0.45% | 61 |
|
|
2018
Q3 | $3.71M | Sell |
10,510
-178
| -2% | -$61.3K | 0.45% | 64 |
|
|
2018
Q2 | $3.1M | Buy |
10,688
+4,340
| +68% | +$1.22M | 0.38% | 81 |
|
|
2018
Q1 | $1.74M | Sell |
6,348
-280
| -4% | -$86.9K | 0.23% | 149 |
|
|
2017
Q4 | $2.11M | Sell |
6,628
-321
| -5% | -$103K | 0.26% | 125 |
|
|
2017
Q3 | $2.18M | Sell |
6,949
-127
| -2% | -$37.6K | 0.28% | 122 |
|
|
2017
Q2 | $1.92M | Buy |
7,076
+330
| +5% | +$87.3K | 0.25% | 137 |
|
|
2017
Q1 | $1.84M | Sell |
6,746
-452
| -6% | -$128K | 0.26% | 124 |
|
|
2016
Q4 | $2.04M | Buy |
7,198
+160
| +2% | +$47.4K | 0.29% | 106 |
|
|
2016
Q3 | $2.2M | Sell |
7,038
-2,599
| -27% | -$770K | 0.33% | 93 |
|
|
2016
Q2 | $2.33M | Sell |
9,637
-340
| -3% | -$89.6K | 0.32% | 95 |
|
|
2016
Q1 | $2.6M | Sell |
9,977
-301
| -3% | -$79.5K | 0.34% | 92 |
|
|
2015
Q4 | $3.15M | Sell |
10,278
-1,149
| -10% | -$330K | 0.4% | 73 |
|
|
2015
Q3 | $3.33M | Buy |
11,427
+141
| +1% | +$46.6K | 0.44% | 60 |
|
|
2015
Q2 | $4.56M | Sell |
11,286
-984
| -8% | -$395K | 0.56% | 42 |
|
|
2015
Q1 | $5.18M | Sell |
12,270
-2,911
| -19% | -$1.15M | 0.57% | 42 |
|
|
2014
Q4 | $5.15M | Sell |
15,181
-835
| -5% | -$270K | 0.51% | 47 |
|
|
2014
Q3 | $5.3M | Sell |
16,016
-513
| -3% | -$169K | 0.52% | 43 |
|
|
2014
Q2 | $5.21M | Sell |
16,529
-3,229
| -16% | -$972K | 0.5% | 44 |
|
|
2014
Q1 | $6.04M | Buy |
19,758
+3,109
| +19% | +$987K | 0.59% | 40 |
|
|
2013
Q4 | $4.66M | Sell |
16,649
-2,378
| -12% | -$615K | 0.42% | 65 |
|
|
2013
Q3 | $4.58M | Buy |
19,027
+1,781
| +10% | +$399K | 0.43% | 68 |
|
|
2013
Q2 | $3.71M | Buy |
+17,246
| New | +$3.69M | 0.36% | 90 |
|
Other funds holding BIIB
VCM
VPM
Sumitomo Life Insurance's BIIB Position: Q1 2026 in Review
Sumitomo Life Insurance increased its Biogen (BIIB) stake by 4.2% in Q1 2026, buying an estimated $12.3K and bringing the position to 1,672 shares worth $307K. The position accounts for 0.01% of the portfolio, ranked #266.
Sumitomo Life Insurance first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.04M in Q1 2014. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Sumitomo Life Insurance held 1,672 shares of Biogen worth $307K as of Q1 2026.
- Sumitomo Life Insurance bought 67 Biogen shares in Q1 2026, an estimated $12.3K.
- Biogen made up 0.01% of Sumitomo Life Insurance's portfolio in Q1 2026, its #266 holding.
- Sumitomo Life Insurance first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Sumitomo Life Insurance's Biogen position peaked at $6.04M in Q1 2014.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.